Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (IPDGC-NIA) C UKPDSBB CL 937 (40%) 1896 (53%) 58 (13) - - - 63 (10) - 9,622

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs7431293 chr3:48187647 CDC25A [-10989bp] A vs. G All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-42) 7.31e-05
rs35142214 chr3:48187743 CDC25A [-10893bp] A vs. G All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-43) 6.30e-05
rs62263001 chr3:48188042 CDC25A [-10594bp] G vs. A All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-44) 6.59e-05
rs4858892 chr3:48188261 CDC25A [-10375bp] C vs. T All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-42) 7.68e-05
rs6442106 chr3:48190815 CDC25A [-7821bp] G vs. A All: C 15 108,990 0.325 (G) 0.292 (G) 1.07 (1.04-1.11) 0 (0-43) 4.91e-05
rs6442107 chr3:48190914 CDC25A [-7722bp] C vs. T All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-45) 6.05e-05
rs7428336 chr3:48191032 CDC25A [-7604bp] A vs. G All: C 15 108,990 0.325 (A) 0.292 (A) 1.07 (1.04-1.11) 0 (0-45) 5.42e-05
rs1551629 chr3:48191998 CDC25A [-6638bp] C vs. T All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-46) 6.47e-05
rs6442109 chr3:48192981 CDC25A [-5655bp] G vs. A All: C 15 108,990 0.325 (G) 0.292 (G) 1.07 (1.04-1.11) 0 (0-46) 4.02e-05
rs7617773 chr3:48193515 CDC25A [-5121bp] C vs. T All: C 15 108,990 0.325 (C) 0.3 (C) 1.07 (1.04-1.11) 0 (0-46) 3.67e-05
rs6771787 chr3:48194242 CDC25A [-4394bp] C vs. T All: C 15 108,990 0.333 (C) 0.292 (C) 1.08 (1.04-1.13) 0 (0-43) 5.02e-05
rs6771889 chr3:48194326 CDC25A [-4310bp] C vs. T All: C 15 108,990 0.325 (C) 0.292 (C) 1.07 (1.04-1.11) 0 (0-46) 3.49e-05
rs9839447 chr3:48194667 CDC25A [-3969bp] T vs. C All: C 15 108,990 0.35 (T) - 1.08 (1.04-1.12) 0 (0-40) 3.44e-05
rs6797587 chr3:48197614 CDC25A [-1022bp] A vs. G All: C 15 108,990 0.317 (A) 0.292 (A) 1.07 (1.04-1.11) 0 (0-45) 4.06e-05
rs9862131 chr3:48202440 CDC25A G vs. A All: C 15 108,990 - - 0.93 (0.90-0.96) 0 (0-46) 3.62e-05
rs13099560 chr3:48204768 CDC25A C vs. T All: C 15 108,990 0.367 (C) 0.192 (C) 1.07 (1.04-1.11) 0 (0-51) 8.06e-05
rs3731555 chr3:48206102 CDC25A A vs. G All: C 15 108,990 0.333 (A) 0.1 (A) 1.08 (1.04-1.11) 0 (0-46) 4.55e-05
rs3731550 chr3:48206583 CDC25A C vs. A All: C 15 108,990 0.325 (C) 0.083 (C) 1.08 (1.04-1.11) 0 (0-47) 4.80e-05
rs3731534 chr3:48211777 CDC25A T vs. C All: C 15 108,990 0.333 (T) 0.092 (T) 1.07 (1.04-1.11) 0 (0-46) 5.81e-05
rs9831531 chr3:48214438 CDC25A A vs. G All: C 15 108,990 - - 0.93 (0.90-0.97) 0 (0-45) 7.19e-05
rs936426 chr3:48215253 CDC25A A vs. G All: C 15 108,990 0.333 (A) 0.117 (A) 1.07 (1.04-1.11) 0 (0-45) 7.96e-05
rs6796490 chr3:48237104 MIR4443 [-950bp] G vs. T All: C 15 108,990 0.333 (G) 0.233 (G) 1.07 (1.04-1.11) 0 (0-52) 7.47e-05
rs11720622 chr3:48246679 MIR4443 [+8573bp] A vs. G All: C 15 108,990 0.333 (A) 0.242 (A) 1.07 (1.03-1.10) 0 (0-53) 2.02e-04
rs13094727 chr3:48323489 ZNF589 A vs. G All: C 15 108,990 0.333 (A) 0.108 (A) 1.06 (1.03-1.10) 0 (0-46) 4.18e-04
rs6788650 chr3:48749543 IP6K2 T vs. C All: C 15 108,990 0.392 (T) 0.042 (T) 0.94 (0.91-0.98) 24 (0-59) 5.30e-04
rs6808104 chr3:48767877 IP6K2 A vs. G All: C 15 108,990 - - 0.91 (0.88-0.95) 33 (0-64) 2.49e-06
rs6799186 chr3:48768680 IP6K2 C vs. T All: C 15 108,990 - - 0.92 (0.88-0.95) 32 (0-63) 5.49e-06
rs140931409 chr3:52726249 GNL3 A vs. C All: C 12 101,324 - - 0.69 (0.57-0.84) 10 (0-49) 1.87e-04
rs143918452 chr3:52816840 ITIH1 G vs. A All: C 13 104,595 - - 0.68 (0.56-0.82) 36 (0-67) 6.28e-05
rs139492471 chr3:52820251 ITIH1 C vs. A All: C 12 101,324 - - 0.67 (0.56-0.81) 12 (0-51) 4.52e-05
rs149318366 chr3:52846203 ITIH4 [-788bp] T vs. C All: C 12 101,324 - - 0.67 (0.55-0.82) 15 (0-55) 7.87e-05
rs117681659 chr3:52847230 ITIH4 C vs. T All: C 12 101,324 - 0.008 (T) 0.67 (0.55-0.82) 15 (0-55) 7.91e-05
rs76451747 chr3:77197581 ROBO2 A vs. C All: C 12 96,250 0.017 (A) 0.067 (A) 2.09 (1.47-2.97) 0 (0-37) 3.68e-05
rs75553291 chr3:77241476 ROBO2 C vs. A All: C 12 96,250 - 0.092 (A) 0.53 (0.39-0.73) 0 (0-38) 9.19e-05
rs77538485 chr3:77250427 ROBO2 T vs. C All: C 12 96,250 - 0.025 (C) 0.57 (0.42-0.77) 0 (0-39) 2.38e-04
rs62267706 chr3:87488120 intergenic A vs. G All: C 8 27,960 0.05 (A) - 1.75 (1.43-2.15) 91 (84-95) 8.52e-08
rs62267708 chr3:87489314 intergenic T vs. C All: C 14 39,208 0.05 (T) - 1.15 (1.03-1.29) 88 (82-92) 0.016
rs115185635 chr3:87520857 intergenic C vs. G All: C 8 27,960 0.05 (C) - 1.79 (1.46-2.19) 91 (85-95) 2.21e-08
rs57255308 chr3:95615843 intergenic C vs. T All: C 9 89,028 - - 0.47 (0.32-0.70) 32 (0-68) 2.15e-04
rs16854322 chr3:143503014 SLC9A9 A vs. G All: C 15 108,990 0.125 (A) 0.15 (A) 0.91 (0.87-0.95) 0 (0-50) 8.55e-05
rs57830957 chr3:143506634 SLC9A9 G vs. A All: C 15 108,990 0.125 (G) 0.492 (G) 0.91 (0.87-0.95) 0 (0-52) 5.00e-05
rs73159835 chr3:143588793 SLC9A9 [+21420bp] C vs. A All: C 14 103,470 0.2 (C) 0.225 (C) 0.91 (0.88-0.95) 33 (0-65) 1.83e-05
rs59707234 chr3:143608199 SLC9A9 [+40826bp] G vs. A All: C 15 108,990 0.258 (G) 0.242 (G) 0.93 (0.90-0.96) 20 (0-56) 7.71e-05
rs11712608 chr3:143613183 SLC9A9 [+45810bp] A vs. C All: C 15 108,990 0.258 (A) 0.275 (A) 0.92 (0.89-0.96) 24 (0-59) 1.00e-05
rs6776821 chr3:143614488 SLC9A9 [+47115bp] G vs. A All: C 14 103,470 - - 1.09 (1.05-1.13) 24 (0-60) 1.97e-05
rs12496928 chr3:143630392 intergenic A vs. G All: C 15 108,990 0.233 (A) 0.233 (A) 0.91 (0.87-0.95) 33 (0-64) 7.71e-06
rs11713552 chr3:155135036 PLCH1 T vs. C All: C 15 108,990 0.45 (T) 0.292 (T) 1.01 (0.98-1.05) 0 (0-49) 0.458
rs13098896 chr3:160752358 PPM1L A vs. G All: C 15 108,990 - - 0.93 (0.90-0.96) 41 (0-68) 5.90e-05
rs9858335 chr3:160760146 PPM1L G vs. A All: C 15 108,990 0.325 (G) 0.25 (A) 1.07 (1.04-1.11) 31 (0-63) 4.73e-05
rs73021215 chr3:160760590 PPM1L C vs. T All: C 15 108,990 - - 0.93 (0.90-0.96) 36 (0-65) 5.75e-05